title: MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish.
abstract: The inv(8)(p11q13) chromosomal abnormality, described in acute myeloid leukaemias (AML), fuses the histone acetyl-transferase (HAT) MYST3 (MOZ) gene with another HAT gene, NCOA2 (TIF2). We generated a transgenic zebrafish in which the MYST3/NCOA2 fusion gene was expressed under control of the spi1 promoter. An AML developed in 2 of 180 MYST3/NCOA2-EGFP-expressing embryos, 14 and 26 months after injection of the fusion gene in a one-cell embryo, respectively. This leukaemia was characterised by an extensive invasion of kidneys by myeloid blast cells. This model, which is the first zebrafish model of AML, demonstrates the oncogenic potency of MYST3/NCOA2 fusion gene.
authors: Inserm UMR 866, Dijon, France.
authors: Julia
authors: J
authors: Zhuravleva
authors: Jérôme
authors: J
authors: Paggetti
authors: Laurent
authors: L
authors: Martin
authors: Arlette
authors: A
authors: Hammann
authors: Eric
authors: E
authors: Solary
authors: Jean-Noël
authors: JN
authors: Bastie
authors: Laurent
authors: L
authors: Delva
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D004195:Disease Models, Animal; D050939:Gene Fusion; D051548:Histone Acetyltransferases / Q000235:genetics* / Q000378:metabolism; D007668:Kidney / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D008845:Microinjections / Q000379:methods; D051958:Nuclear Receptor Coactivator 2 / Q000235:genetics* / Q000378:metabolism; D015514:Oncogene Proteins, Fusion / Q000235:genetics* / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D015027:Zebrafish / Q000235:genetics
chemical_list: C498001:NCOA2 protein, human; D051958:Nuclear Receptor Coactivator 2; D015514:Oncogene Proteins, Fusion; D051548:Histone Acetyltransferases; C108712:KAT6A protein, human